Absence of the association with CC chemokine receptor 5 polymorphism in polymyalgia rheumatica

Clinical and Experimental Rheumatology

Volumn 18, Issue 5, 2000, Pages 591-595

  Salvarani, C ^a   Boiardi, L ^a   Timms, J M ^a   Silvestri, T ^a   Ranzi, A ^a   Macchioni, P L ^a   Pulsatelli, L ^a   Di Giovine, L S ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

CCR5 polymorphism; Polymyalgia rheumatica; Relapse recurrence

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CORTICOSTEROID; RANTES;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR BINDING; RHEUMATIC POLYMYALGIA; SYMPTOMATOLOGY;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; ALLELES; BASE PAIRING; FEMALE; GENE DELETION; GENE FREQUENCY; GENOTYPE; HUMAN; MALE; MIDDLE AGE; POLYMORPHISM (GENETICS); POLYMYALGIA RHEUMATICA; RANTES; RECEPTORS, CCR5; REFERENCE VALUES;

EID: 0033813784     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991
2. Polymyalgia rheumatica
3. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment
4. Chemokines and leukocyte traffic
5. Elevated serum concentrations of the chemokine RANTES in patients with polymyalgia rheumatica
6. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
7. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant by human eosinophils
8. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines
9. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
10. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
11. Chemokine receptor allelic polymorphisms: Relationship to HIV resistance and disease progression
12. Impaired macrophage function and enhanced T cell-dependent immune response in mice lackng CCR5, the mouse homologue of the major HIV-1 co-receptor
13. Long-term follow-up of polymyalgia rheumatica: Evidence for synovitis
14. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
15. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
16. Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: A sequential study
17. Increased prevalence of antibodies to adenovirus and respiratory syncytial virus in polymyalgia rheumatica
18. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection
19. Proximal bursitis in active polymyalgia rheumatica
20. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease
21. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis
22. The CCR5 deletion mutation fails to protect against multiple sclerosis
23. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors
24. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5
25. CC chemokine receptor 5 polymorphism in rheumatoid arthritis
26. The delta 32 deletion of CCR5 receptor in rheumatoid arthritis